Stock and Flow of Peritoneal Dialysis Patients Australia

Slides:

Advertisements

Similar presentations

ANZDATA Registry Annual Report 2013 STOCK AND FLOW CHAPTER 1.

Advertisements

Copyright © 2010, 2007, 2004, 2000, Mosby, Inc., an affiliate of Elsevier Inc. All Rights Reserved. Focus on Dialysis and Kidney Transplant (Relates to.

End Stage Kidney Disease Treatment Modalities Australia New Zealand Dec 2012 Prepared by Debbie Fortnum Kidney Health Australia Data courtesy of ANZDATA.

HAEMODIALYSIS CHAPTER 5. © ANZDATA Registry Figure 5.1 Stock and Flow of Haemodialysis Patients Australia Patients new.

© ANZDATA Registry Method and Location of Dialysis 1453 (30%) 632 (13%) 1317 (27%) 1335 (27%) Number of Patients Australia 31-Dec-96.

ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition PERITONEAL DIALYSIS CHAPTER 6.

Kevan Polkinghorne Aarti Gulyani Stephen McDonald Kylie Hurst CHAPTER 5 HAEMODIALYSIS (including home haemodialysis) 2012 Annual Report—35th Edition ANZDATA.

CHAPTER 5: PAEDIATRIC RENAL REPLACEMENT THERAPY Lee Ming Lee Lim Yam Ngo Lynster Liaw Susan Pee Yap Yok Chin Wan Jazilah Wan Ismail Source: 21 st MDTR.

ANZDATA Registry Overview Dr Graeme Russ Darwin September 2001 September 2001.

CHAPTER 13 RENAL TRANSPLANTATION Editor: Dr. Goh Bak Leong Expert Panel: Dato’ Dr. Zaki Morad b Mohd Zaher (Chair) Dr. Goh Bak Leong (Co-Chair) Dr. Fan.

© ANZDATA Registry Method and Location of Dialysis (31%) 634 (12%) 1396 (26%) 1523 (28%) Number of Patients Australia 30-Sep-98 METHA.BRIS98.

Chapter 5 Peritoneal Dialysis 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013 ANZDATA gratefully acknowledges the contributions of the Peritoneal.

Chapter 12 End Stage Kidney Disease among Indigenous Peoples of Australia and New Zealand 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013.

© ANZDATA Registry Prevalence and Incidence End Stage Renal Failure - Australia ( ) Per Million Functioning Transplant (259) New Pts (82) Deaths.

STOCK AND FLOW CHAPTER 1. © ANZDATA Registry Figure 1.1 Prevalent Patients (Number Per Million Population at 31st December)

Blair Grace Kylie Hurst Stephen McDonald CHAPTER 1 STOCK AND FLOW 2012 Annual Report—35th Edition ANZDATA Registry Annual Report 2012.

© ANZDATA Registry Stock and Flow of CAPD Patients Australia Number of Patients 1504 Patients * (Data to 30 Sept) Extrapolated.

UK Renal Registry 16th Annual Report Figure Median height z-scores for transplant patients

END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES OF AUSTRALIA AND NEW ZEALAND CHAPTER 12.

UK Renal Registry 15th Annual Report Figure 7.1. Median height z-scores for transplant patients

Figures from Dialysis and kidney transplantation in Australia 1991–2010.

USRDS USRDS 2002 adr Incident counts by initial modality figure 7.1 patients age 19 years & younger.

USRDS 2000 ADR USRDS Cadaveric donations by gender & race figure 7.1, patients aged

END-STAGE KIDNEY DISEASE AMONG 2013 Annual Report - 36th Edition

Volume 59, Issue 2, Pages (February 2001)

First-year death rates by modality figure 8

West Midlands Renal Peer Review

Prevalence (pmp) of Renal Replacement Therapy

December 31st point prevalent counts by modality figure 3.1

The CANUSA Trial Reference

CHAPTER 6 PERITONEAL DIALYSIS Fiona Brown Aarti Gulyani

2013 Annual Report - 36th Edition

CHAPTER 5 Paediatric Renal Replacement Therapy

Table 4.1: Cumulative distribution of QoL-Index score in relation to dialysis modality, all dialysis patients

CHAPTER 11: Haemodialysis Practices

CHAPTER 3 Death and Survival on Dialysis

Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique.

METHOD AND LOCATION OF DIALYSIS CHAPTER 4.

Volume 64, Pages S3-S12 (December 2003)

ANZDATA Registry Annual Report 2013

CHAPTER 1 All Renal Replacement Therapy In Malaysia

CHAPTER 3 DEATHS Stephen McDonald 2012 Annual Report—35th Edition

Volume 73, Issue 4, Pages (February 2008)

Cause Specific Death Rates for All Dialysis Patients

What really happens to people on long-term peritoneal dialysis?

Stephen P. McDonald Kidney International Supplements

2013 Annual Report - 36th Edition

Peritoneal dialysis adequacy and risk of death

ANZDATA Registry 41st Annual Report Highlights of End Stage Kidney Disease in Australia and New Zealand Data to 31-Dec-2017.

Randomized controlled study of biocompatible peritoneal dialysis solutions: Effect on residual renal function S.L.S. Fan, T. Pile, S. Punzalan, M.J.

Forest plot showing the association between center-level characteristics and death-censored technique failure after adjusting for age, sex, race, body.

Stephen P. Mcdonald, Graeme R. Russ Kidney International

American Journal of Kidney Diseases

Volume 59, Issue 2, Pages (February 2001)

Mary B. Leonard, Lynn A. Donaldson, Martin Ho, Denis F. Geary

Dialysis outcomes in Australia & New Zealand

International Donor Statistics 2000

Number of Donors in Australia

ANZDATA Peritoneal Dialysis Report

Stock and Flow of Haemodialysis Patients Australia

Prevalent Dialysis and Transplants Australia (at 31st December) Number of Patients

Demographic Characteristics of Cohort

CHAPTER 12 END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES

Stock and Flow of Peritoneal Dialysis Patients Australia

Stock and Flow of Peritoneal Dialysis Patients Australia

Stock and Flow of Peritoneal Dialysis Patients Australia

Stock and Flow of Haemodialysis Patients Australia

Australia and New Zealand

Australia and New Zealand

Presentation transcript:

Stock and Flow of Peritoneal Dialysis Patients Australia 1994 - 2000 Number of Patients New Patients Transplants Perm. Transfer Deaths No. Dialysing 1723 Patients 94 95 96 97 98 99 00

Stock and Flow of Peritoneal Dialysis Patients New Zealand 1994 - 2000 Number of Patients New Patients Transplants Perm. Transfer Deaths No. Dialysing 677 Patients 94 95 96 97 98 99 00

Age of New PD Patients No. Pats. 15 26 61 66 121 174 206 104 6

Age of Dialysing PD Patients No. Pats. 25 51 114 152 280 350 505 234 12

PD Patients (%) of all Dialysis

Number (Per Million) PD Patients Australia 1996 - 2000

APD Patients (%) of all Dialysis

Number (Per Million) APD Patients Australia 1996 - 2000

PD Patients (%) of all Dialysis

Number (Per Million) PD Patients New Zealand 1996 - 2000

APD Patients (%) of all Dialysis

Number (Per Million) APD Patients New Zealand 1996 - 2000

Age of New PD Patients No. Pats. 5 4 13 24 49 80 55 29 1

Age of Dialysing PD Patients No. Pats. 6 17 38 67 135 201 153 56 4

Australia 1997 - 2001 BMI <20  

New Zealand 1997 - 2001 BMI <20  

Australia 1997 - 2001 BMI 20 - 24.9  

New Zealand 1997 - 2001 BMI 20 - 24.9  

Australia 1997 - 2001 BMI 25 - 29.9  

New Zealand 1997 - 2001 BMI 25 - 29.9  

Australia 1997 - 2001 BMI  30  

New Zealand 1997 - 2001 BMI  30  

First PD Treatment to First Peritonitis Related to Age at Entry 1997 - 2000 % Survival Australia Age Group 

First PD Treatment to First Peritonitis Related to Age at Entry 1997 - 2000 % Survival New Zealand Age Group 

Peritonitis Free Survival Related to Race Australia 1992-1995 Caucasoid 35-54 yrs 55-64 yrs 35-54 yrs 55-64 yrs Aboriginal Maori/Pac Isl

Peritonitis Free Survival Related to Race Australia 1997-2000 Caucasoid 35-54 yrs 55-64 yrs 35-54 yrs Aboriginal Maori/Pac Isl 55-64 yrs

Peritonitis Free Survival Related to Race New Zealand 1992-1995 Caucasoid 55-64 yrs 35-54 yrs Maori/Pac Isl 35-54 yrs 55-64 yrs

Peritonitis Free Survival Related to Race New Zealand 1997-2000 Caucasoid 55-64 yrs 35-54 yrs Maori/Pac Isl 35-54 yrs 55-64 yrs

Relationship of Residual GFR to Kt/V Achieved Kt/V March 2001 Australia New Zealand Mean  1 SD

Creatinine Clearance (Litres/Week) Relationship of Creatinine Clearance to Kt/V Creatinine Clearance (Litres/Week) March 2001 Australia New Zealand Mean  1 SD

Patient Survival Related to Referral (HD Treatment at 90 days) 1997 to Mar-2001 Australia

Technique Survival Related to Referral (HD Treatment at 90 days) 1997 to Mar-2001 Australia Death Censored

Patient Survival Related to Referral (PD Treatment at 90 days) 1997 to Mar-2001 Australia

Technique Survival Related to Referral (PD Treatment at 90 days) 1997 to Mar-2001 Australia Death Censored

Patient Survival Related to Referral (HD Treatment at 90 days) 1997 to Mar-2001 New Zealand

Technique Survival Related to Referral (HD Treatment at 90 days) 1997 to Mar-2001 New Zealand Death Censored

Patient Survival Related to Referral (PD Treatment at 90 days) 1997 to Mar-2001 New Zealand

Technique Survival Related to Referral (PD Treatment at 90 days) 1997 to Mar-2001 New Zealand Death Censored

Delayed Graft Function 1990 - 2000 According to Type of Dialysis CD1 Grafts Australia Chi-square p<0.001

Australia Primary Cadaver Graft Survival 1990 - 2000 According to Type of Dialysis Australia p = n.s Years